LLY vs TMO · P/E 39, rev $22.97B vs P/E 24, rev $23.00B
Eli Lilly and Company (LLY) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the LLY and TMO stock pages for the full models.
Not investment advice.